Testing effectiveness (Phase 2)Study completedNCT05361031
What this trial is testing
The Safety and Tolerability of Engensis (VM202) in Patients With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A)
Who this might be right for
CMT
Helixmith Co., Ltd. 12